Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet
Conditions
- Bioavailability
- Healthy Subjects
Interventions
- DRUG: Ticagrelor OD tablet (90 mg single dose) administered with 200 ml of water
- DRUG: Ticagrelor OD tablet (90 mg single dose) administered without water
- DRUG: Ticagrelor OD tablet (90 mg single dose) suspended in water administered via nasogastric tube
- DRUG: Brilique®, Ticagrelor IR tablet (90 mg) administered with 200mL of water
Sponsor
AstraZeneca